Vol. 01 · Issue 004
Australia's Healthcare Pulse
Reference Pricing, Scribes & Sovereignty
Reference pricing pushes medicines off the PBS; the TGA moves to compliance action on AI scribes; Grattan calls for the end of Community Pharmacy Agreements
11 September 2026
A twelve-week catch-up issue covering five domains across 13 strategic items — four medicine pricing disputes that converged into one structural story, the TGA shifting from guidance to enforcement on the AI tool already used by two in five GPs, Grattan's case for abolishing Community Pharmacy Agreements, an interoperability mandate with dated retirements running to 2029, and the finding that only 3 of 1,357 FDA-cleared AI devices have been tested on patient outcomes.
Issue Highlights
- TGA moves to compliance action on AI scribes
- Only 3 of 1,357 FDA-cleared AI devices tested on outcomes
- Harrison.ai cuts AU roles after $32M to stay
- Grattan: abolish Community Pharmacy Agreements
- ADHA mandates AU Core; legacy standards retired by 2029
- Reference pricing pushes MS and cancer medicines to the exit
Read Full Issue →
~18 min read